Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
Mitoxantrone inhibits and downregulates ERα through binding at the DBD-LBD interface
Han Wang, Yuxuan Luo, Sandeep Artham…·Sichun Yang
This study shows mitoxantrone inhibits ERα by binding at the DBD-LBD interface, causing conformational changes and degradation, and effectively targets ER mutations resistant to current therapies.
DOI 10.1158/1535-7163.mct-25-0405